Concurrent RNA and DNA Sequencing Improves Variant Detection
By Elana Gotkine HealthDay Reporter
THURSDAY, Nov. 9, 2023 -- Performing RNA sequencing concurrently with DNA sequencing improves detection of novel variants and classification of existing variants, according to a study published online Nov. 4 in JAMA Oncology to coincide with the annual meeting of the American Society of Human Genetics, held from Nov. 1 to 5 in Washington, D.C.
Carolyn Horton, from Ambry Genetics in Aliso Viejo, California, and colleagues performed paired DNA and RNA testing on individuals undergoing germline testing for a hereditary cancer indication at a single diagnostic laboratory. A total of 43,524 individuals were included, with 43,599 tests. The main outcomes examined included an increase in diagnostic yield and reduction in the rate of variants of uncertain significance (VUS).
The researchers found that variant classification was impacted in 1.3 percent of participants (549 individuals). Overall, 97 individuals had medically significant upgrades made, including 70 who had a variant reclassified from VUS to pathogenic/likely pathogenic (P/LP) and 27 who had a novel deep intronic P/LP variant that would not have been identified using DNA sequencing alone. Overall, 17.1 percent of 545 P/LP splicing variants were dependent on RNA evidence for classification and 71.1 percent of 439 existing splicing VUS were resolved by RNA evidence. Compared with White individuals, Asian, Black, and Hispanic individuals combined had a higher increase in positive rate and decrease in VUS rate (3.1 versus 1.6 percent and −3.9 versus −2.5 percent, respectively).
"This diagnostic study highlights the importance of RNA sequencing in precision medicine to improve the identification of high-risk individuals missed by DNA-only diagnostic approaches and the medical management of tested patients," the authors write.
All authors were paid employees of Ambry Genetics, which funded the study; two authors disclosed ties to other biotechnology companies.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
Mortality in Rheumatic Heart Disease Is High
FRIDAY, June 7, 2024 -- Mortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June...
Higher County-Level Prostate Cancer Screening Tied to Better Outcomes
FRIDAY, June 7, 2024 -- Higher county-level prevalence of prostate-specific antigen (PSA) screening is associated with lower odds of advanced disease, all-cause mortality, and...
Metabolic Impact on Offspring Similar for Frozen, Fresh Embryo Transfer
FRIDAY, June 7, 2024 -- For glucose and lipid profiles during early childhood, the impact of frozen embryo transfer (FET) is comparable to that of fresh embryo transfer, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.